Clinical spectrum of neuromuscular complications after immune checkpoint inhibition.

Puwanant, Araya; Isfort, Michael; Lacomis, David; Zivkovic, Sasa A

Puwanant, Araya; Isfort, Michael; Lacomis, David; Zivkovic, Sasa A.

Afiliación

Puwanant A; Department of Neurology, University of Pittsburgh Medical Center, 3471 Fifth Ave #810, Pittsburgh, PA 15213, United States.
Isfort M; Department of Neurology, University of Pittsburgh Medical Center, 3471 Fifth Ave #810, Pittsburgh, PA 15213, United States.
Lacomis D; Department of Neurology, University of Pittsburgh Medical Center, 3471 Fifth Ave #810, Pittsburgh, PA 15213, United States; Department of Pathology (Neuropathology), University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Zivkovic SA; Department of Neurology, University of Pittsburgh Medical Center, 3471 Fifth Ave #810, Pittsburgh, PA 15213, United States. Electronic address: zivkovics@upmc.edu.

Neuromuscul Disord ; 29(2): 127-133, 2019 02.

Article en En | MEDLINE | ID: mdl-30638612

Asunto(s)

Antineoplásicos Inmunológicos/efectos adversos; Debilidad Muscular/inducido químicamente; Miastenia Gravis/inducido químicamente; Miositis/inducido químicamente; Neoplasias/tratamiento farmacológico; Humanos

Palabras clave

Immune checkpoint inhibitors; Myasthenia gravis; Myopathy; Neuromuscular; Neuropathy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Debilidad Muscular / Antineoplásicos Inmunológicos / Miastenia Gravis / Miositis / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Neuromuscul Disord Asunto de la revista: NEUROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google